晶华微(688130) - 晶华微投资者关系活动记录表

Group 1: Company Overview - The company, Hangzhou Jinghua Microelectronics Co., Ltd., focuses on the development of SoC chips for medical health and industrial control applications [2][3]. Group 2: Revenue Breakdown - In the first three quarters of 2023, the revenue breakdown for the company's main business was as follows: - Medical health SoC chips accounted for 54.52% - Industrial control and instrumentation chips accounted for 43.87% - Intelligent perception SoC chips accounted for 1.62% [3]. Group 3: Client Relationships - The company has established partnerships with notable clients, including: - Medical health SoC chips: Xiangshan Weighing, Lexin Medical, and Wolai Technology - Industrial control and instrumentation chips: Youlide, Huashengchang, Victory Instruments, and Dongfang Instruments [3]. Group 4: Product Development - The company is launching multiple R&D projects this year, focusing on various analog signal chain products and linear products. Some high-speed, high-bit, single-channel, and multi-channel ADC chips are currently undergoing testing with key clients [3][4]. - New products are also expected in the fields of medical health, industrial instrumentation, and battery management [3]. Group 5: Future Performance Expectations - The company anticipates performance improvements in Q4 and next year, with a focus on increasing market share and expanding scale. A draft for the 2023 Restricted Stock Incentive Plan has been released, linking revenue to performance assessment [4].